Aterian, Inc. (ATER) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 3.37%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value -17.67×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 3.37% | Share-based compensation / revenue. Period ending 2026-06-30. $2.32M ÷ $68.85M × 100 ≈ 3.37% |
| Interest coverage · 12 months | -17.67× | Operating income ÷ reported interest expense. $-18.22M ÷ $1.03M ≈ -17.67× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 68.85M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 2.32M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -18.22M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 1.03M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $68.85M | $2.32M | $-18.22M | $1.03M | (m) | 3.37% | -17.67× | Reported |
| 2026-03-31 | (m) | $68.93M | $2.03M | $-17.84M | $970.00K | (m) | 2.95% | -18.39× | Reported |
| 2025-12-31 | (m) | $68.97M | $2.18M | $-17.97M | $957.00K | (m) | 3.16% | -18.78× | Reported |
| 2025-09-30 | (m) | $78.45M | $2.75M | $-11.86M | $1.01M | (m) | 3.51% | -11.78× | Reported |
| 2025-06-30 | (m) | $85.67M | $3.83M | $-11.54M | $1.00M | (m) | 4.47% | -11.51× | Reported |
| 2025-03-31 | (m) | $94.19M | $6.63M | $-10.24M | $1.05M | (m) | 7.03% | -9.79× | Reported |
| 2024-12-31 | $0.00 | $99.05M | $7.51M | $-11.82M | $1.22M | 0.00% | 7.58% | -9.71× | Reported |
| 2024-09-30 | $808.00K | $107.19M | $7.96M | $-18.45M | $1.46M | 0.75% | 7.42% | -12.61× | Reported |
| 2024-06-30 | $1.66M | $120.62M | $7.38M | $-23.24M | $1.68M | 1.38% | 6.12% | -13.85× | Reported |
| 2024-03-31 | $3.37M | $127.90M | $7.69M | $-56.47M | $1.92M | 2.63% | 6.01% | -29.38× | Reported |
| 2023-12-31 | $4.62M | $142.57M | $8.34M | $-76.19M | $2.13M | 3.24% | 5.85% | -35.85× | Reported |
| 2023-09-30 | $5.24M | $164.71M | $9.51M | $-90.74M | $2.28M | 3.18% | 5.77% | -39.87× | Reported |
| 2023-06-30 | $6.09M | $191.37M | $11.22M | $-193.17M | $2.69M | 3.18% | 5.86% | -71.70× | Reported |
| 2023-03-31 | $6.12M | $214.38M | $14.05M | $-166.86M | $2.49M | 2.85% | 6.55% | -67.01× | Reported |
| 2022-12-31 | $6.01M | $221.17M | $14.59M | $-178.16M | $2.70M | 2.72% | 6.60% | -66.08× | Reported |
| 2022-09-30 | $7.20M | $229.59M | $19.51M | $-158.63M | $2.82M | 3.14% | 8.50% | -56.19× | Reported |
| 2022-06-30 | $8.26M | $231.38M | $26.14M | $-57.22M | $4.84M | 3.57% | 11.30% | -11.83× | Reported |
| 2022-03-31 | $8.86M | $241.30M | $24.95M | $-42.62M | $9.30M | 3.67% | 10.34% | -4.58× | Reported |
| 2021-12-31 | $9.84M | $247.77M | $28.99M | $-34.08M | $13.25M | 3.97% | 11.70% | -2.57× | Reported |
| 2021-09-30 | $8.77M | $225.94M | $26.57M | $-49.95M | $14.33M | 3.88% | 11.76% | -3.49× | Reported |
| 2021-06-30 | $7.85M | $216.60M | $21.87M | $-42.32M | $12.37M | 3.62% | 10.10% | -3.42× | Reported |
| 2021-03-31 | $7.97M | $208.21M | $22.18M | $-48.61M | $8.66M | 3.83% | 10.65% | -5.61× | Reported |
| 2020-12-31 | $8.13M | $185.70M | $22.72M | $-34.75M | $5.04M | 4.38% | 12.23% | -6.90× | Reported |
| 2020-09-30 | $9.51M | $169.85M | $27.41M | $-33.11M | $4.25M | 5.60% | 16.14% | -7.79× | Reported |
| 2020-06-30 | $10.89M | $151.67M | $33.92M | $-47.29M | $4.25M | 7.18% | 22.36% | -11.13× | Reported |
| 2020-03-31 | $11.78M | $122.23M | $40.62M | $-61.06M | $4.45M | 9.64% | 33.23% | -13.72× | Reported |
| 2019-12-31 | $10.66M | $114.45M | $34.68M | $-54.33M | $4.53M | 9.31% | 30.30% | -11.99× | Reported |
| 2019-09-30 | (m) | (m) | (m) | $27.29M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | $32.99M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | $29.40M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $22.60M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HELEN OF TROY LTD (HELE) | $0.685B | -1.53 |